fatigue with glp-1 What Happens After GLP-1 Weight
Description
Set your commitment
PMID 20122128
Hence, GLP-1RAs can be utilized as an adjunct alongside metformin as a first-line treatment for type 2 DM or, in specific cases, as a preferred therapeutic agent when additional benefits for cardiovascular or renal protection are required [84]
Limitations Despite these strengths, several limitations must be acknowledged
A well-matched population was found in the GLP-1RAs vs metformin groups ( n =47,097 each) after PSM (ESM Figs 2 and 3)
By acting early, we helped improve affordability and get ahead of a rapidly evolving GLP-1 pipeline
